TCV Trust & Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.7M | Buy |
23,074
+49
| +0.2% | +$50.1K | 2.1% | 11 |
|
|
2026
Q1 | $21.2M | Sell |
23,025
-481
| -2% | -$488K | 1.77% | 14 |
|
|
2025
Q4 | $25.3M | Buy |
23,506
+226
| +1% | +$216K | 2.04% | 10 |
|
|
2025
Q3 | $17.8M | Sell |
23,280
-55
| -0.2% | -$40.9K | 1.49% | 17 |
|
|
2025
Q2 | $18.2M | Sell |
23,335
-682
| -3% | -$530K | 1.59% | 15 |
|
|
2025
Q1 | $19.8M | Buy |
24,017
+19
| +0.1% | +$15.8K | 1.84% | 12 |
|
|
2024
Q4 | $18.5M | Buy |
23,998
+236
| +1% | +$195K | 1.71% | 14 |
|
|
2024
Q3 | $21.1M | Sell |
23,762
-759
| -3% | -$682K | 1.89% | 10 |
|
|
2024
Q2 | $22.2M | Sell |
24,521
-253
| -1% | -$202K | 2.12% | 9 |
|
|
2024
Q1 | $19.3M | Sell |
24,774
-474
| -2% | -$337K | 1.85% | 13 |
|
|
2023
Q4 | $14.7M | Sell |
25,248
-178
| -0.7% | -$104K | 1.48% | 21 |
|
|
2023
Q3 | $13.7M | Buy |
25,426
+778
| +3% | +$401K | 1.51% | 23 |
|
|
2023
Q2 | $11.6M | Buy |
24,648
+491
| +2% | +$206K | 1.23% | 32 |
|
|
2023
Q1 | $8.3M | Buy |
24,157
+22,734
| +1,598% | +$7.67M | 0.92% | 39 |
|
|
2022
Q4 | $521K | Sell |
1,423
-100
| -7% | -$35.5K | 0.06% | 137 |
|
|
2022
Q3 | $492K | Sell |
1,523
-92
| -6% | -$29.1K | 0.06% | 132 |
|
|
2022
Q2 | $524K | Sell |
1,615
-80
| -5% | -$24K | 0.06% | 132 |
|
|
2022
Q1 | $485K | Sell |
1,695
-2,400
| -59% | -$618K | 0.05% | 142 |
|
|
2021
Q4 | $1.13M | Hold |
4,095
| – | – | 0.11% | 109 |
|
|
2021
Q3 | $946K | Buy |
4,095
+2,445
| +148% | +$603K | 0.1% | 109 |
|
|
2021
Q2 | $379K | Hold |
1,650
| – | – | 0.04% | 153 |
|
|
2021
Q1 | $308K | Sell |
1,650
-75
| -4% | -$14.7K | 0.04% | 155 |
|
|
2020
Q4 | $291K | Hold |
1,725
| – | – | 0.04% | 156 |
|
|
2020
Q3 | $256K | Sell |
1,725
-15
| -0.9% | -$2.32K | 0.03% | 160 |
|
|
2020
Q2 | $286K | Sell |
1,740
-60
| -3% | -$9.21K | 0.04% | 151 |
|
|
2020
Q1 | $250K | Sell |
1,800
-875
| -33% | -$120K | 0.04% | 146 |
|
|
2019
Q4 | $351K | Sell |
2,675
-100
| -4% | -$11.6K | 0.04% | 148 |
|
|
2019
Q3 | $311K | Hold |
2,775
| – | – | 0.04% | 160 |
|
|
2019
Q2 | $307K | Sell |
2,775
-50
| -2% | -$5.89K | 0.04% | 166 |
|
|
2019
Q1 | $367K | Sell |
2,825
-230
| -8% | -$28K | 0.05% | 157 |
|
|
2018
Q4 | $354K | Sell |
3,055
-45
| -1% | -$5.03K | 0.05% | 156 |
|
|
2018
Q3 | $333K | Hold |
3,100
| – | – | 0.04% | 166 |
|
|
2018
Q2 | $265K | Buy |
+3,100
| New | +$255K | 0.04% | 181 |
|
|
2018
Q1 | – | Sell |
-2,610
| Closed | -$220K | – | 204 |
|
|
2017
Q4 | $220K | Sell |
2,610
-475
| -15% | -$40.4K | 0.03% | 186 |
|
|
2017
Q3 | $264K | Buy |
+3,085
| New | +$253K | 0.04% | 167 |
|
|
2016
Q3 | – | Sell |
-2,625
| Closed | -$207K | – | 167 |
|
|
2016
Q2 | $207K | Buy |
+2,625
| New | +$198K | 0.04% | 160 |
|
Other funds holding LLY
SC
TCV Trust & Wealth Management's LLY Position: Q2 2026 in Review
TCV Trust & Wealth Management increased its Eli Lilly (LLY) stake by 0.21% in Q2 2026, buying an estimated $50.1K and bringing the position to 23,074 shares worth $27.7M. The position accounts for 2.1% of the portfolio, ranked #11.
TCV Trust & Wealth Management first reported a position in LLY in Q2 2016 and has held it in 36 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- TCV Trust & Wealth Management held 23,074 shares of Eli Lilly worth $27.7M as of Q2 2026.
- TCV Trust & Wealth Management bought 49 Eli Lilly shares in Q2 2026, an estimated $50.1K.
- Eli Lilly made up 2.1% of TCV Trust & Wealth Management's portfolio in Q2 2026, its #11 holding.
- TCV Trust & Wealth Management first reported a position in Eli Lilly in Q2 2016 and has held it in 36 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on TCV Trust & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.